WikiMD is world's largest health encyclopedia with
28,557 pages, 3,991,215 edits & 34,290,934 views.
7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521
A selective, orally bioavailable inhibitor of 17beta-hydroxysteroid dehydrogenase type 5 (17bHSD5, aldo-keto reductase 1C3; AKR1C3), with potential antineoplastic activity. Upon administration, ASP9521 selectively binds to and inhibits the activity of 17bHSD5. This prevents the conversion of the adrenal androgens dehydroepiandrosterone and androstenedione into 5-androstenediol and testosterone. By blocking testosterone production, ASP9521 may inhibit the growth of testosterone-dependent cancers such as castration-resistant prostate cancer (CRPC). 17bHSD5, expressed both in normal prostate tissue and in prostate cancer (PC), plays a crucial role in persistent production of androgens despite castration; its expression is associated with increased malignancy of PC.
External links
WikiMD needs you!
This WikiMD article 7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521 is a stub.
If you are a healthcare professional familiar with the topic 7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521, or
A subject matter expert or authority on 7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521, you can help us.
About | Mission | Paid editors welcome!
| 7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521 is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
